Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.38M Buy
109,572
+24,425
+29% +$360K 0.01% 1318
2025
Q3
$1.31M Sell
85,147
-57,852
-40% -$933K ﹤0.01% 1396
2025
Q2
$2.25M Buy
142,999
+10,285
+8% +$156K 0.01% 1064
2025
Q1
$2.53M Sell
132,714
-79,249
-37% -$1.73M 0.01% 988
2024
Q4
$5.05M Buy
211,963
+61,765
+41% +$1.72M 0.02% 683
2024
Q3
$4.21M Sell
150,198
-30,823
-17% -$870K 0.02% 779
2024
Q2
$4.73M Buy
181,021
+10,644
+6% +$221K 0.02% 707
2024
Q1
$3.73M Buy
170,377
+116,974
+219% +$2.51M 0.02% 879
2023
Q4
$1.24M Sell
53,403
-10
-0% -$201 0.01% 1419
2023
Q3
$1.05M Buy
+53,413
New +$1.05M 0.01% 1419
2022
Q4
$871K Buy
+51,372
New +$911K 0.01% 1526

Other funds holding RXO

Comerica Bank's RXO Position: Q4 2025 in Review

Comerica Bank increased its RXO (RXO) stake by 29% in Q4 2025, buying an estimated $360K and bringing the position to 109,572 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #1318.

Comerica Bank first reported a position in RXO in Q4 2022 and has held it in 11 quarters since. The position peaked at $5.05M in Q4 2024. 269 funds tracked by Wall St. Rank hold RXO as of Q4 2025.

  • Comerica Bank held 109,572 shares of RXO worth $1.38M as of Q4 2025.
  • Comerica Bank bought 24,425 RXO shares in Q4 2025, an estimated $360K.
  • RXO made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1318 holding.
  • Comerica Bank first reported a position in RXO in Q4 2022 and has held it in 11 quarters since.
  • Comerica Bank's RXO position peaked at $5.05M in Q4 2024.
  • 269 funds tracked by Wall St. Rank held RXO as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.